Study Participants
Approximately 600 people with confirmed SARS-CoV-2 infection at least six months before the examination date will be examined.
On the one hand, participants of the population-based Gutenberg COVID-19 Study (GCS) with a past SARS-CoV-2 infection will be invited to the examination. Extensive preliminary data - including (sub)clinical phenotyping and molecular data such as protein profiles and genetics - are already available for these participants.
On the other hand, individuals who have received inpatient care / intensive care at the University Medical Center Mainz due to a COVID-19 disease will be examined.
Participation in the study is only possible upon explicit invitation.
HERE you can find answers to frequently asked questions.
On the one hand, participants of the population-based Gutenberg COVID-19 Study (GCS) with a past SARS-CoV-2 infection will be invited to the examination. Extensive preliminary data - including (sub)clinical phenotyping and molecular data such as protein profiles and genetics - are already available for these participants.
On the other hand, individuals who have received inpatient care / intensive care at the University Medical Center Mainz due to a COVID-19 disease will be examined.
Participation in the study is only possible upon explicit invitation.
HERE you can find answers to frequently asked questions.